|
Volumn 32, Issue 6, 2005, Pages 803-807
|
Phase I study of concurrent radiotherapy with TS-1 and vitamin A (TAR Therapy) for head and neck cancer
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
OXONIC ACID;
PYRIDINE DERIVATIVE;
RETINOL;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
HEAD AND NECK TUMOR;
HUMAN;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
PHASE 1 CLINICAL TRIAL;
QUALITY OF LIFE;
RADIATION DOSE;
SQUAMOUS CELL CARCINOMA;
ADULT;
AGED;
ANOREXIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
OXONIC ACID;
PYRIDINES;
QUALITY OF LIFE;
RADIOTHERAPY DOSAGE;
TEGAFUR;
VITAMIN A;
|
EID: 21244469511
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|